Clinical Trials

Showing trials with last updates posted in 2026.

NCT04071236 | SUSPENDED | PHASE1/PHASE2
90 participants

Radiation Medication (Radium-223 Dichloride) Versus Radium-223 Dichloride Plus Radiation Enhancing Medication (M3814) Versus Radium-223 Dichloride Plus M3814 Plus Avelumab (a Type of Immunotherapy) for Advanced Prostate Cancer Not Responsive to Hormonal Therapy

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-31
Start Date:
2020-10-14
Completion:
2027-04-30
Conditions
  • Metastatic Castration-Resistant Prostate Carcinoma
  • Metastatic Malignant Neoplasm in the Bone
  • Metastatic Malignant Neoplasm in the Lymph Nodes
  • Stage IVB Prostate Cancer AJCC v8
Interventions
  • DRUG
  • PROCEDURE
  • OTHER
  • RADIATION
No Results Yet
NCT03973281 | COMPLETED | NA
420 participants

EASE: The Materna Prep Pivotal Study

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-31
Start Date:
2019-12-11
Completion:
2026-07-30
Conditions
  • Vaginal Delivery
  • Pelvic Organ Prolapse
Interventions
  • DEVICE
  • OTHER
No Results Yet
NCT03793166 | ACTIVE_NOT_RECRUITING | PHASE3
1175 participants

Immunotherapy With Nivolumab and Ipilimumab Followed by Nivolumab or Nivolumab With Cabozantinib for Patients With Advanced Kidney Cancer, The PDIGREE Study

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-31
Start Date:
2019-06-07
Completion:
2028-01-25
Conditions
  • Clear Cell Renal Cell Carcinoma
  • Metastatic Malignant Neoplasm in the Bone
  • Metastatic Malignant Neoplasm in the Lymph Nodes
  • Metastatic Malignant Neoplasm in the Soft Tissue
  • Metastatic Malignant Neoplasm in the Viscera
  • Rhabdoid Tumor of the Kidney
  • Sarcomatoid Renal Cell Carcinoma
  • Stage III Renal Cell Cancer AJCC v8
  • Stage IV Renal Cell Cancer AJCC v8
Interventions
  • PROCEDURE
  • DRUG
  • BIOLOGICAL
  • OTHER
No Results Yet
NCT03739814 | RECRUITING | PHASE2
84 participants

Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-31
Start Date:
2019-05-08
Completion:
2027-02-01
Conditions
  • B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative
  • Recurrent B Acute Lymphoblastic Leukemia
  • Refractory B Acute Lymphoblastic Leukemia
Interventions
  • PROCEDURE
  • BIOLOGICAL
  • DRUG
No Results Yet
NCT03505320 | ACTIVE_NOT_RECRUITING | PHASE2
143 participants

A Study of Zolbetuximab (IMAB362) in Adults With Gastric Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-31
Start Date:
2018-06-29
Completion:
2027-06-30
Conditions
  • Pharmacokinetics of Zolbetuximab
  • Gastric Cancer
  • Gastro-esophageal Junction (GEJ) Cancer
  • Pharmacokinetics of Oxaliplatin
  • Pharmacokinetics of Fluorouracil Bolus (5-FU)
Interventions
  • DRUG
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page